Tenofovir: What We Have Learnt After 7.5Â Million Person-Years of Use [PDF]
, 2015 core +1 more source
Addressing model overcomplexity in drug-drug interaction prediction with molecular fingerprints. [PDF]
J CheminformGil-Sorribes M, Molina A.
europepmc +1 more source
Validation of a LC-MS/MS Assay for Rapid and Simultaneous Quantification of Cobicistat and Venetoclax in Human Plasma and Serum. [PDF]
Biomed ChromatogrWestra N +5 more
europepmc +1 more source
Cobicistat/darunavir/cobicistat/darunavir/emtricitabine/tenofovir-alafenamide/darunavir/ritonavir [PDF]
Reactions Weekly, 2020 openaire +1 more source
Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review. [PDF]
Front PharmacolSpanakis M, Alexakis K, Ioannou P.
europepmc +1 more source
The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV. [PDF]
Infect Dis TherZheng Y +16 more
europepmc +1 more source
Dual Long-Acting Cabotegravir/Rilpivirine Plus Lenacapavir in Integrase Strand Transfer Inhibitor Resistance: A Case Report and Review of the Literature. [PDF]
Open Forum Infect DisSeo L, Reilly-Evans B, Garland J.
europepmc +1 more source
Tracing the evolution of polypharmacy and contraindicated drug‒drug interactions in people living with HIV in Belgium. [PDF]
Front PharmacolLopez Delhoulle V +5 more
europepmc +1 more source
To Switch or not to Switch: are there any Antiretroviral Strategies to Attenuate Weight Gain in People with HIV? [PDF]
Curr HIV/AIDS RepDebroy P, Lake JE.
europepmc +1 more source